Occult carcinoma in prophylactic oophorectomy specimens: Prevalence and association with BRCA germline mutation status

American Journal of Surgical Pathology

Volumn 25, Issue 10, 2001, Pages 1283-1289

  Colgan, T J ^a   Murphy, J ^a   Cole, D E C ^a   Narod, S ^a   Rosen, B ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

BRCA; Fallopian tube carcinoma; Ovarian carcinoma; Prophylactic oophorectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; OCCULT CANCER; OVARIECTOMY; OVARY CARCINOMA; PRIMARY PREVENTION; PROPHYLAXIS; SALPINGECTOMY; UTERINE TUBE TUMOR;

CYSTADENOCARCINOMA, PAPILLARY; DNA, NEOPLASM; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; OMENTUM; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PROSPECTIVE STUDIES; RNA, NEOPLASM; UTERUS;

EID: 0034810223     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200110000-00009     Document Type: Article

References (37)

1. Tumors of the fimbriated end of the fallopian tube: A clinicopathologic analysis of 20 cases, including nine carcinomas
2. A genetic epidemiological study of carcinoma of the fallopian tube
3. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylacticoophorectomy specimens from BRCA1 heterozygotes
4. Molecular approaches to management of epithelial ovarian cancer
5. Early de novo ovarian carcinoma
6. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
7. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II: BRCA1 and BRCA2. Cancer Genetics Studies Consortium
8. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds
9. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome
10. Ovarian dysplasia in epithelial inclusion cysts: A morphometric approach using neural networks
11. Characterization of ovarian dysplasia by interactive morphometry
12. Ovarian dysplasia in prophylactic oophorectomy specimens: Cytogenetic and morphometric correlations
13. Pathology of early malignant change in the ovary
14. Hereditary cancer syndromes
15. Six families prone to ovarian cancer
16. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
17. Ovarian dysplasia
18. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations
19. BRCA1 germline mutations in women with uterine serous papillary carcinoma
20. Occult ovarian tumours in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
21. Contralateral ovary in unilateral ovarian carcinoma: A search for preneoplastic lesions
22. Ovarian cancer: Screening, treatment, and follow-up
23. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis
24. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian carcinoma
25. Ovarian intraepithelial neoplasia demonstrated in stage 1 ovarian carcinoma
26. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
27. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies
28. Histopathologic features of ovaries at increased risk for carcinoma: A case control analysis
29. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation
30. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
31. Prophylactic oophorectomy in inherited breast/ovarian cancer families
32. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families
33. Immunohistochemical localization of c-erB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumors of the ovary
34. Ovarian cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
35. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer
36. Familial ovarian cancer and early ovarian cancer: Biologic, pathologic, and clinical features
37. Is ovarian cancer associated with an increased frequency of germinal inclusion cysts?